Enoxolone (18-β-glycyrrhetinic acid) has been widely used as a topical anti-inflammatory compound. Due to its terpenoid chemical structure related to steroids, it has never been excluded that it could act at least in part, as a glucocorticoid-like drug. In an animal model of inflammation, phorbol ester-induced mouse ear oedema, enoxolone effects were not inhibited by treatment with RU38486, a glucocorticoid-receptor antagonist whereas dexamethasone effects were inhibited by this agent. The results demonstrate that the enoxolone anti-inflammatory mechanism of action is not related to glucocorticoid receptor interaction.
Read full abstract